Veracyte | VCYT - Pre Tax Profit


Veracyte reported $26.52M in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
Agenus USD 39.21M 49.82M Mar/2026
Agilent USD 364M 78M Dec/2025
Anika Therapeutics USD 764K 3M Dec/2025
Arrowhead Research USD -137.56M 165.84M Mar/2026
Bruker USD 117M 95.1M Jun/2026
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Illumina USD 260M 103M Jun/2026
Intrexon USD -60.48M 27.09M Jun/2024
Karyopharm Therapeutics USD -22.39M 17.51M Mar/2026
Laboratory Of America USD 8.61B 121.8M Jun/2026
Ligand Pharmaceuticals USD -24.26M 81.04M Mar/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Rigel Pharmaceuticals USD -1.03M 7.22M Jun/2024
Roche Holding CHF 11.17B 6.38B Jun/2026
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Siemens EUR 2.86B 89M Mar/2026
Sonic Healthcare AUD 402.01M 53.16M Jun/2025
Thermo Fisher Scientific USD 1.73B 389M Mar/2026
Veracyte USD 26.52M 3.45M Jun/2026
Waters USD -88M 352.18M Mar/2026